About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in California | 1,848 Studies

Clinical Trials Breast CancerCalifornia

Breast Cancer Clinical Trials in California

Find 1,848 clinical trials for breast cancer near California. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 741-760 of 1,848 trials

CompletedOxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer SurvivorsThis phase II trial studies how well oxaloacetate works in reducing cognitive complaints in stage 0-IIIA breast cancer survivors.NCT04290897·Los Angeles, California CompletedThis Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast CancerThis is a study in adult patients with different types of cancer.NCT03099174·Santa Monica, California and 29 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedRadiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases.NCT00003162·Birmingham, Alabama and 252 others

Not yet recruitingBiology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE TrialThis clinical trial tests the feasibility and utility of a biology guided therapy recommendations report to aid in determining treatment of hormone receptor positive breast cancer…NCT07590583·Duarte, California and 1 other

Not yet recruitingNeu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast CancerThe goal of this clinical trial is to learn if neratinib, an FDA-approved oral pan-HER2/3/4 inhibitor, improves disease control for participants with metastatic…NCT07729046·La Jolla, California

CompletedPhase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer PatientsThis is a phase 2, randomized, placebo controlled, multi-center study to estimate the treatment effect and evaluate the safety and tolerability of AMG 386 in combination with…NCT00511459·Litchfield Park, Arizona and 76 others

CompletedProject Connect Online: An Internet-based Intervention for Women With Breast CancerThis randomized comparative effectiveness trial examines the potential psychosocial and physical health-related benefits of sharing personal websites with other women with breast…NCT02866994·Los Angeles, California

TerminatedTreatment Resistance Following Anti-cancer TherapiesThe TRANSLATE study aims to better understand why tumors become resistant to standard anti-cancer therapies.NCT04436120·Daphne, Alabama and 32 others

RecruitingA Study of LY4175408 in Participants With Advanced CancerThe purpose of this study is to measure the safety and efficacy of LY4175408 in participants with selected advanced cancer.NCT07046923·Stanford, California and 26 others

UnknownVR for Surgical Prehabilitation and RehabilitationThis randomized controlled trial aims to determine feasibility and acceptability of of VR-physical therapy modules for surgical patients undergoing breast or axilla surgery in…NCT06334380·Palo Alto, California

Active not recruitingT-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialThis phase III trial compares the effect of usual treatment with trastuzumab emtansine (T-DM1) alone vs. T-DM1 in combination with tucatinib.NCT04457596·Birmingham, Alabama and 1175 others

CompletedCryoablation of Low Risk Small Breast Cancer- ICE3 TrialTo evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer .NCT02200705·Glendale, Arizona and 18 others

RecruitingMicrobiome and Association With Implant InfectionsThe most common tissue expander-related infections are from Staphylococcus and Pseudomonas species.NCT05020574·San Francisco, California

CompletedNiraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian CancerThis Phase 1/2 study will evaluate the safety and efficacy of combination treatment with niraparib and pembrolizumab (MK-3475) in patients with advanced or metastatic…NCT02657889·Birmingham, Alabama and 29 others

CompletedStudy of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast CancerThis is a pilot phase 1b study to investigate the safety and side effects of combining the ROR1-targeting monoclonal antibody, cirmtuzumab, with paclitaxel for patients with HER2…NCT02776917·La Jolla, California

RecruitingImmune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast CancerThis phase I trial studies the side effects and best dose of M5A-IL2 immunocytokine (M5A-ICK) combined with stereotactic body radiation therapy (SBRT) and to see how well they…NCT06130826·Duarte, California

CompletedA Study of TAS-120 in Patients With Advanced Solid TumorsThis is an open-label, nonrandomized, Phase 1/2 study for the fibroblast growth factor receptor (FGFR) inhibitor futibatinib (TAS-120).NCT02052778·Gilbert, Arizona and 57 others

CompletedEducation With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node DissectionThis randomized phase III trial studies how well education with or without physical therapy intervention works in preventing lymphedema in women with stage I, II, or III breast…NCT00376597·Castro Valley, California and 75 others

CompletedGTI-2040 and Capecitabine in Treating Patients With Metastatic Breast CancerThis phase II trial is studying how well giving GTI-2040 together with capecitabine works in treating patients with metastatic breast cancer.NCT00068588·Sacramento, California

CompletedKindness Interventions in Enhancing Well-Being in Breast Cancer SurvivorsEmerging evidence suggests that both extending kindness towards others and self-kindness practices may have beneficial effects on well-being.NCT03319342·Los Angeles, California and 1 other

PreviousPage 38 of 93Next

Other Conditions in California

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma